Europe Food Safety Testing Market Trends and Insights
Rising Foodborne Illness Incidence and Outbreaks
The surge in foodborne illness cases across Europe has created unprecedented demand for comprehensive pathogen testing services. UK Health Security Agency data reveals Salmonella cases reached a decade high of 10,388 cases in 2024, representing a 17.1% increase from 2023 levels. The multi-country Salmonella Mbandaka outbreak linked to pre-cooked frozen chicken demonstrated the critical role of whole-genome sequencing in cross-border outbreak investigation, driving adoption of molecular diagnostic capabilities across European testing laboratories. This trend particularly benefits laboratories with advanced WGS infrastructure and rapid turnaround capabilities, as regulatory authorities increasingly rely on molecular epidemiology for source attribution and control measures. The emphasis on ready-to-eat product testing has intensified following multiple contamination events, creating sustained demand for specialized microbiological testing protocols.Advancements In Testing Technologies and Rapid Methods
Laboratory automation and rapid analytical methods are transforming European food testing operations, driven by workforce shortages and demand for faster turnaround times. The integration of robotics-based solutions, NMR automation, and AI-enabled data analysis is enabling laboratories to increase throughput while reducing manual handling errors. Near-infrared spectroscopy (NIR) and laser-induced breakdown spectroscopy (LIBS) are gaining regulatory acceptance as sustainable alternatives to traditional wet chemistry methods, eliminating solvent usage and reducing environmental footprint. However, regulatory acceptance remains constrained, particularly in Germany, where normative methods still dominate official controls. The development of portable mass spectrometry and handheld spectroscopy devices is creating new market opportunities for on-site testing, though validation and standardization challenges persist. These technological advances are particularly relevant for ISO 17025 accredited laboratories seeking to maintain competitive advantage through operational efficiency.High Costs of Advanced Testing Equipment and Methods
The substantial capital requirements for state-of-the-art analytical instrumentation create barriers for smaller testing laboratories seeking to expand service capabilities. Advanced mass spectrometry systems, automated sample preparation equipment, and molecular diagnostic platforms require investments often exceeding USD 500,000 per instrument, constraining market entry for regional players. This cost structure favors larger, established laboratories with sufficient scale to justify equipment investments and maintain utilization rates. The ongoing shift toward more sophisticated testing methods, including untargeted screening approaches and multi-residue analysis, further escalates operational costs through specialized consumables and highly trained personnel requirements. Smaller laboratories increasingly rely on outsourcing arrangements or consolidation strategies to access advanced analytical capabilities, contributing to market concentration trends.Other drivers and restraints analyzed in the detailed report include:
- Growing Consumer Awareness and Demand for Transparency and Label Accuracy
- Demand For Organic, Pesticide-free, Allergen-free Products
- Complex Regulatory Heterogeneity Across Countries
Segment Analysis
Advanced molecular diagnostic methods are revolutionizing pathogen detection capabilities across European food testing laboratories, with Pathogen Testing commanding 53.12% market share in 2025. The segment's dominance reflects the critical importance of microbiological safety in preventing foodborne illness outbreaks, particularly following high-profile incidents like the multi-country Salmonella Mbandaka outbreak that highlighted the need for rapid, accurate pathogen identification European Centre for Disease Prevention and Control. GMO Testing emerges as the fastest-growing segment at 6.56% CAGR (2026-2031), driven by evolving EU regulations on New Genomic Techniques and increasing consumer scrutiny of bioengineered ingredients.Pesticide and Residue Testing maintains significant market presence, supported by EFSA's comprehensive monitoring programs that analyzed 88,141 food samples in 2023, demonstrating the scale of regulatory requirements. Mycotoxin Testing gains importance due to climate change impacts on crop contamination patterns, while Allergen Testing expands alongside growing dietary restriction awareness and cross-contamination prevention requirements. Other Contaminant Testing, including heavy metals and process contaminants, addresses emerging regulatory concerns such as PFAS limits and acrylamide monitoring. The segment's evolution toward multi-analyte screening platforms reflects laboratories' efforts to improve efficiency while meeting diverse analytical requirements across food categories.
Complete Report Scope:
- By Contaminant Type
- Pathogen Testing
- Pesticide and Residue Testing
- Mycotoxin Testing
- GMO Testing
- Allergen Testing
- Other Contaminant Testing
- By Technology
- Polymerase Chain Reaction
- Immunoassay-based
- Chromatography and Spectrometry
- Others
- By Application
- Pet Food and Animal Feed
- Food
- Meat and Poultry
- Dairy
- Fruits and Vegetables
- Processed Food
- Crops
- Other Foods
- By Geography
- Germany
- United Kingdom
- Italy
- France
- Spain
- Netherlands
- Poland
- Belgium
- Sweden
- Rest of Europe
List of Companies Covered in this Report:
- SGS Société Générale de Surveillance SA
- Eurofins Scientific SE
- Bureau Veritas SA
- Intertek Group plc
- ALS Limited
- TÜV SÜD AG
- TÜV Rheinland AG
- TÜV NORD GROUP
- Merieux NutriSciences Corporation
- Synlab AG
- Neogen Corporation
- Microbac Laboratories, Inc.
- AsureQuality Limited
- Bio-Rad Laboratories, Inc.
- 3M Company
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Romer Labs Division Holding GmbH
- LGC Limited
- Fera Science Limited
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- SGS Société Générale de Surveillance SA
- Eurofins Scientific SE
- Bureau Veritas SA
- Intertek Group plc
- ALS Limited
- TÜV SÜD AG
- TÜV Rheinland AG
- TÜV NORD GROUP
- Merieux NutriSciences Corporation
- Synlab AG
- Neogen Corporation
- Microbac Laboratories, Inc.
- AsureQuality Limited
- Bio-Rad Laboratories, Inc.
- 3M Company
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Romer Labs Division Holding GmbH
- LGC Limited
- Fera Science Limited

